Theranostic Application of Radiohalogens in Nuclear Medicine.

IF 2.7 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Nuclear Medicine and Molecular Imaging Pub Date : 2025-10-01 Epub Date: 2025-08-16 DOI:10.1007/s13139-025-00937-x
Choong Mo Kang
{"title":"Theranostic Application of Radiohalogens in Nuclear Medicine.","authors":"Choong Mo Kang","doi":"10.1007/s13139-025-00937-x","DOIUrl":null,"url":null,"abstract":"<p><p>Radiohalogens, including fluorine-18 (F-18) and radioiodine (I-123, I-124, and I-131), have been utilized widely for both diagnostic imaging and targeted radionuclide therapy owing to their favorable nuclear properties, well-established radiochemistry, and broad applicability to biomolecules. Among the diverse radionuclides utilized in this field, the production of astatine-211, a promising alpha-emitting radiohalogen, has expanded globally, stimulating a growing interest in theranostic applications that leverage the unique properties of radiohalogens. This review article provides an overview of radiohalogens in nuclear medicine, discussing their current status and future prospects in theranostic radiopharmaceuticals.</p>","PeriodicalId":19384,"journal":{"name":"Nuclear Medicine and Molecular Imaging","volume":"59 5","pages":"306-314"},"PeriodicalIF":2.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12446170/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear Medicine and Molecular Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13139-025-00937-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Radiohalogens, including fluorine-18 (F-18) and radioiodine (I-123, I-124, and I-131), have been utilized widely for both diagnostic imaging and targeted radionuclide therapy owing to their favorable nuclear properties, well-established radiochemistry, and broad applicability to biomolecules. Among the diverse radionuclides utilized in this field, the production of astatine-211, a promising alpha-emitting radiohalogen, has expanded globally, stimulating a growing interest in theranostic applications that leverage the unique properties of radiohalogens. This review article provides an overview of radiohalogens in nuclear medicine, discussing their current status and future prospects in theranostic radiopharmaceuticals.

放射性卤素在核医学中的治疗应用。
放射性卤素,包括氟-18 (F-18)和放射性碘(I-123、I-124和I-131),由于其良好的核特性、完善的放射化学和对生物分子的广泛适用性,已广泛用于诊断成像和靶向放射性核素治疗。在这一领域使用的各种放射性核素中,有前途的α发射放射性卤素砹-211的生产已在全球范围内扩大,激发了人们对利用放射性卤素独特性质的治疗应用的日益浓厚的兴趣。本文综述了放射性卤素在核医学中的应用现状,并对其在放射性药物治疗中的应用前景进行了展望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nuclear Medicine and Molecular Imaging
Nuclear Medicine and Molecular Imaging RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
2.20
自引率
7.70%
发文量
58
期刊介绍: Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) is an official journal of the Korean Society of Nuclear Medicine, which bimonthly publishes papers on February, April, June, August, October, and December about nuclear medicine and related sciences such as radiochemistry, radiopharmacy, dosimetry and pharmacokinetics / pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal specially welcomes works of artificial intelligence applied to nuclear medicine. The journal will also welcome original works relating to molecular imaging research such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Nucl Med Mol Imaging publishes the following types of papers: original articles, reviews, case reports, editorials, interesting images, and letters to the editor. The Korean Society of Nuclear Medicine (KSNM) KSNM is a scientific and professional organization founded in 1961 and a member of the Korean Academy of Medical Sciences of the Korean Medical Association which was established by The Medical Services Law. The aims of KSNM are the promotion of nuclear medicine and cooperation of each member. The business of KSNM includes holding academic meetings and symposia, the publication of journals and books, planning and research of promoting science and health, and training and qualification of nuclear medicine specialists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信